NielsenIQ at Saudi Food Show: How Saudi Arabian Shoppers Successfully Navigate a Sea of Change
31.7.2023 09:00:00 EEST | Business Wire | Press release
The aftershocks of the COVID-19 pandemic and the resultant shifts in the Saudi Arabian retail space, as well as food inflation, have generated a pullback on promotions, coupled with price increases. This has created a challenging environment for Saudi Arabian shoppers who have adapted quickly by shifting towards convenience and essential products.
This was the view of Andrey Dvoychenkov, NielsenIQ Middle East General Manager, as an introduction to the very first Saudi Food Show held in Riyadh and attended by a host of local and international retail professionals. His NielsenIQ presentation entitled Navigating Disruption During Times of Change provided the latest insights into the Saudi Arabian Fast Moving Consumer Goods (FMCG) sector.
Dvoychenkov said; “The Saudi market has recently been driven by price increases, with some prices raised by 10 to 15% during the year, which is mostly due to the rising cost of raw materials.” Dvoychenkov also highlighted the uniqueness of the Saudi Arabian market “where the majority of products and raw materials are imported, making it essential for industry players to navigate supply chain disruptions and consider local substitutes to create more stability.”
Dvoychenkov reported that as a result consumers in Saudi Arabia are scaling back on spending and optimising their budgets due to various lifestyle changes. These changes include cooking at home more often, minimizing waste and spending less on clothing and grooming.
An interesting dynamic is that despite their intention to curtail spending, Saudi shoppers seem to care deeply about quality. The premium product segment is growing ahead of the economy segment for local and international brands in food, with 65% of Saudi shoppers saying they are willing to pay more for quality products.
In terms of their response to the current challenging conditions they face, tactics that consumers are employing include weighing up the attributes that matter most, shopping online to get the best deals, and stopping buying certain categories of products. Interestingly, despite these changes and turbulent times, consumers in Saudi Arabia have the lowest percentage globally in perceiving themselves to be in a recession.
Dvoychenkov indicated that Saudi shoppers primarily spend their shopping time in hypermarkets and supermarkets, but there is a noticeable trend of faster growth in smaller format stores, such as grocery and convenience stores. The price increase in groceries is also significantly lower in these smaller format stores compared to traditional supermarkets.
The essence of "essentials" for modern shoppers
When it comes to choice and product selection, 77% of Saudi shoppers feel that food prices have increased and are only willing to buy essentials. Regarding the definition of "essentials" for modern shoppers, Dvoychenkov emphasized the need to be careful in how this term is perceived. To today's shoppers, essential products include staple items like bread with health benefits, like gluten-free flour that offer intrinsic benefits.
In addition, the NielsenIQ analysis highlighted the growing importance of health and wellness in consumers' minds, with many shoppers in Saudi Arabia willing to pay more for products containing healthy supplements, supporting the immune system, and made with natural ingredients.
The soaring rise of e-commerce and convenience formats
The presentation also revealed a significant 45% growth in online sales (Q1, 2023 vs. a year ago), with e-commerce playing an increasingly important role in the region. Dvoychenkov explained, “e-commerce growth is driven not only by convenience but also by an appetite for discounts. Online platforms offer a wide range of products, including ready-to-eat meals and foods catering to diverse consumer preferences.”
He added, “Convenience formats are also on the rise, with retailers like Viva, Gala, and Tamimi Express actively driving the expansion of these formats, offering everyday low prices and tailored assortments to meet consumers' convenience-seeking needs.”
The retailers' and manufacturers' challenge
With the changing market dynamics, retailers and manufacturers need to adapt their strategies to meet evolving consumer demands. For Saleem Iftikhar*, Country Leader for NielsenIQ in Saudi Arabia: “Price matching, direct price-cutting campaigns, and loyalty-building initiatives are some of the propositions retailers are adopting to cater to price-conscious consumers while providing a pleasant shopping experience.”
The NielsenIQ study finally emphasizes the importance of offering a well-organized store with a pleasant ambience, as well as excellent customer service. “Consumers are increasingly seeking price and promotion-related saving strategies, and although promo efficiency has seen a slight decline, our analysis highlights the need for retailers to engage customers through various components, including price and entertainment,” concludes Dvoychenkov.
* Saleem Iftikhar led a panel discussion with Chris Abboud, PepsiCo, and Shehim Mohammed, Lulu Group, on the first day of Saudi Food Summit - “Mitigating uncertainty, volatility and cost hikes in Food & Beverage industry.”
About NIQ
NIQ is the world’s leading consumer intelligence company, delivering the most complete understanding of consumer buying behaviour and revealing new pathways to growth. In 2023, NIQ combined with GfK, bringing together the two industry leaders with unparalleled global reach. With a holistic retail read and the most comprehensive consumer insights – delivered with advanced analytics through state-of-the-art platforms – NIQ delivers the Full View (TM).
NIQ is an Advent International portfolio company, with operations in 100+ markets, covering more than 90% of the world’s population. For more information, visit www.NIQ.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230730000521/en/
Contact information
Media
Melina Mammidou (Melina.Mammidou@nielseniq.com)
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
